Reckitt Benckiser first-quarter sales miss estimates

FILE PHOTO: Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic, are seen in London, Britain February 12, 2008. REUTERS/Stephen Hird/File Photo - Copyright Stephen Hird(Reuters)

By Reuters

Published on 02/05/2019 - 09:34•Updated 24/04/2024 - 11:35

Comments

LONDON (Reuters) - Reckitt Benckiser Group reported lower-than-expected first-quarter sales on Thursday, citing a slow start to the year in its health business.

The maker of Strepsils and Mucinex cold medicine and Lysol cleaners said like-for-like sales rose 1 percent in the first quarter. Analysts on average were expecting sales on that basis to rise 1.8 percent, according to a company-supplied consensus.